Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab

Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab

Abstract Background To compare the reoperation rate in patients with vitreous hemorrhage (VH) secondary to proliferative diabetic retinopathy (PDR) with or without preoperative intravitreal bevacizumab (IVB). Methods In this retrospective study, 280 patients (362 eyes) with diabetic VH were divided...

Full description

Bibliographic Details
Main Authors: Xuting Hu, Qintuo Pan, Jingwei Zheng, Zongming Song, Zongduan Zhang
Format: Article
Language:English
Published: BMC 2019-09-01
Series:BMC Ophthalmology
Subjects:
Vitrectomy
Intravitreal bevacizumab
Proliferative diabetic retinopathy
Vitreous hemorrhage
Reoperation
Online Access:http://link.springer.com/article/10.1186/s12886-019-1179-x

Internet

http://link.springer.com/article/10.1186/s12886-019-1179-x

Similar Items